Symphony Trial Shows Faster Diabetic Foot Ulcer Healing

Integra LifeSciences lowered its full-year guidance below Street forecasts, citing a July flooding event that impacted its Cincinnati facility. The company cut its adjusted EPS outlook to $2.30 to $2.40 and its revenue outlook to $1.634 billion to $1.654 billion, down from previous estimates of $2.40 to $2.50 and $1.654 billion to $1.695 billion, and below the consensus of $2.46 and $1.67 billion. Integra also reported preliminary third-quarter 2026 results of roughly $410 million to $412 million in revenue and $0.55 to $0.59 of adjusted EPS, compared with consensus of $416.3 million and $0.56. CEO Stuart Essig said the company now has a clearer understanding of the expected impact on its third-quarter results and full-year outlook as it gained visibility into the recovery timeline and production ramp. Separately, Integra announced plans to secure a $600 million loan as part of a broader refinancing drive, a proposed seven-year Senior Secured Term Loan B expected to help pay down debt and cover associated fees and expenses.

CollPlant Biotechnologies completed its acquisition of photonic computing pioneer LightSolver in September 2026, a deal that closed after the quarter and therefore is not reflected in the company's reported second-quarter results. For the three months ended June 30, 2026, CollPlant reported GAAP revenues of $108,000, down from $179,000 a year earlier on lower sales of rhCollagen-based products, and a GAAP net loss of $2.7 million, or $1.89 basic loss per share, compared with a net loss of $3.3 million, or $2.83 basic loss per share, in the prior-year quarter. Six-month GAAP revenues fell to $181,000 from $2.2 million, a decline the company attributed primarily to a $2.0 million development milestone payment from a former business collaborator recognized in 2025 that did not recur, while the six-month GAAP net loss widened to $5.8 million, or $4.13 basic loss per share, from $4.8 million, or $4.12 basic loss per share. CollPlant said joint research by LightSolver and the High-Performance Computing Center Stuttgart, published in the ACM proceedings, demonstrated projected time-to-solution acceleration ranging from approximately 40 times to more than 80,000 times compared with state-of-the-art GPU-based algorithms, depending on the benchmark problem and algorithm evaluated. Following the closing, CollPlant appointed LightSolver CEO and co-founder Dr. Ruti Ben Shlomi to its Board of Directors, and the company ended the quarter with $2.6 million in cash and cash equivalents.